Results 221 to 230 of about 170,525 (342)

Association of maternal biliary disease with hepatopancreatobiliary morbidity in offspring

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Maternal biliary disease is common, but the link with offspring hepatopancreatobiliary disease has not been studied. We assessed the association between maternal biliary disease and pediatric hepatopancreatobiliary morbidity. Methods We conducted a retrospective cohort study of 1,271,864 children born between 2006 and 2022 in Quebec,
Nathalie Auger, Angela Magri, Sarit Kang‐Auger, Gabrielle Jutras, Jessica Healy‐Profitós, Marianne Bilodeau‐Bertrand, Gabriel Côté‐Corriveau   +6 more
wiley   +1 more source

AI in steatohepatitis diagnostics: precision beyond the microscope. [PDF]

Ann Med Surg (Lond)
Ejaz A, Ahmed MM, Khalid M, Talha M, Waafira A.   +4 more
europepmc   +1 more source

Association of histologic disease activity with progression of nonalcoholic fatty liver disease [PDF]

, 2019
Brundt, Elizabeth M, et al,, Kleiner, David E   +2 more
core   +1 more source

Odevixibat after liver transplant in patients with progressive familial intrahepatic cholestasis type 1: A case series

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Patients with progressive familial intrahepatic cholestasis type 1 (PFIC1) who have undergone liver transplantation (LT) may have unmet needs and impacts on daily life due to post‐LT complications, including diarrhea and hepatic steatosis.
Georg‐Friedrich Vogel, Simone Kathemann, Andrea Pietrobattista, Giuseppe Maggiore, Denise Aldrian, Marco Sciveres, Henkjan J. Verkade, Etienne Sokal, Giulia Jannone, Magdalena Salcedo, Peter Rauschkolb, Christof Maucksch, Velichka Valcheva, Elke Lainka   +13 more
wiley   +1 more source

Utilization of Noninvasive Tests to Diagnose At-Risk Metabolic Dysfunction-Associated Steatohepatitis. [PDF]

, 2023
Mazen Noureddin
openalex  

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

The Lancet, 2016
M. Armstrong, P. Gaunt, G. Aithal, D. Barton, D. Hull, R. Parker, J. Hazlehurst, K. Guo, G. Abouda, M. Aldersley, Deborah D. Stocken, S. Gough, J. Tomlinson, Rachel M. Brown, S. Hübscher, P. Newsome   +15 more
semanticscholar   +1 more source

The Proteomic Profiling of Circulating Extracellular Vesicles of Western Diet and Chemical‐Induced Murine MASH Model

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is an increasingly prevalent chronic liver condition that can progress to severe complications such as metabolic dysfunction‐associated steatohepatitis (MASH). Despite its growing burden, there are no reliable non‐invasive biomarkers for tracking disease progression.
Szu‐Jen Wang, Yung‐Ho Wang, Jee‐Fu Huang, En‐Sheng Lin, Wei‐Shiun Chen, Chia‐Yang Li, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu, Shu‐Chi Wang   +9 more
wiley   +1 more source

A Phase 2a Trial of Myeloperoxidase Inhibitor Mitiperstat in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis. [PDF]

Liver Int
Armisen J, Flor A, Eriksson J, Nelander K, Bhattacharya CS, Sunnåker M, Carter D, Trebski M, Gårdmark E, Aurell M, Whatling C, Challis B, Vespasiani-Gentilucci U, COSMOS Investigators.   +13 more
europepmc   +1 more source

Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice [PDF]

, 2010
Jamil Haque, Ryan S. McMahan, Jean S. Campbell, Masami Shimizu‐Albergine, Angela Wilson, Dianne Botta, Theo K. Bammler, Richard P. Beyer, Thomas J. Montine, Matthew M. Yeh, Terrance J. Kavanagh, Nelson Fausto   +11 more
openalex   +1 more source

Therapeutic Potential of Quercetin, Silibinin, and Crocetin in a High-Fat Diet-Induced Mouse Model of MASLD: The Role of CD36 and PLIN3. [PDF]

Life (Basel)
Sotiropoulou M, Katsaros I, Vailas M, Papachristou F, Papakyriakopoulou P, Kostomitsopoulos N, Giatromanolaki A, Valsami G, Tsaroucha A, Schizas D.   +9 more
europepmc   +1 more source